Pariser, Robert J., M.D.
Quick facts
Phase 2 pipeline
- Glycopyrronium 2.4 % Medicated Cloth
Glycopyrronium blocks muscarinic receptors on sweat glands, reducing acetylcholine-stimulated sweat production.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Related
- Sector hub: All tracked pharma companies